1/ Proud to be a part of this hot-off-the-press #stewardship study examining time to blood culture positivity by pathogen and primary service. A joint effort by scientists at @ChildrensColo @CUMedicalSchool @CUAnschutz. Check it out #IDTwitter ! Summary 🧵
pubmed.ncbi.nlm.nih.gov/34407980/#:~:t…
2/ Some background:
* Historically, infants and children are given antibiotics until blood cultures are negative at 48-72 hours.
*Empirically treating is essential for children with bacteremia, but waiting for this negative BC period may be unnecessary. pubmed.ncbi.nlm.nih.gov/25567785/
3/ Why we did this study:
* Understanding the time it takes for blood cultures to become positive (with respect to certain organisms and subspecialties) can help shorten overall antimicrobial duration.

*Shortening duration= fewer adverse events, less resistance, shorter stays
4 / What we did:
* Retrospective analysis of 6,184 blood cultures with positive results over a 6-year period at a large quaternary-care pediatric hospital.
* Included:
-All pts who had BC drawn from Jan 2013- Dec 2018
-Only 1st pos results included
5/ What we did (continued)
*A cx was considered a 1st pos if it had a new organism or if 2 weeks had elapsed since previous positive cx.
*Demographic and #microbiology data were collected
*Cx collect date and date/time that growth was first reported to providers collected
6/ The #microbiology
*#Lab uses standardized BC methods
*Routine BCs incubated for 5 days
*When pos --> Gram stain, BCID (PCR), sub-cultured to BAP/MAC/CHOC/BRUC & incubated (and specialty media added as necessary i.e., chromogenic media or CNA)
7/ The #microbiology continued...
* Media plates incubated for 18-24 hours and examined for growth.
*Orgs identified by MALDI-TOF MS and/or basic biochemical methods
8/ How we categorized things:
*Organisms were categorized into Gram-positive definite pathogens, Gram-negative definite pathogens, Gram-positive possible pathogens, yeast, common contaminants, and "other uncommon definite pathogens" (<30 BCs + for that org during study period)
9/ How we categorized things, continued:
* Possible pathogens were defined as those treated by the primary team with directed antimicrobial agents >= 3 days
* Contaminants defined as those that were either not treated, or treated <3 days
10 / The stats:
*Time to positivity (TTP) was calculated based on the date/time a cx was collected and when the GS was first reported by microbiology to the clinician.
*# of pts who would need to be treated for 48 hrs vs 36 to prevent 1 case of abx termination before pos result
11/ Results
*After exclusions, 2,148 positive BC results were analyzed
* 69% grew definite or possible pathogens
*31% grew common contaminants
*68% of cultures were pos at 24 hours
*87% of cultures were pos at 36 hours
*93% of cultures were post at 48 hours
12 /
* When looking at ALL blood cultures obtained during the 6-year period (89,663), only 125 cultures (0.14%) were positive between 36 and 48 hours.
* The median TTP for all included BCs positive for bacteria during this study period was 19.83 (14.4-26.0)
13 / Broken down by organism category, median TTP:
* Gram-pos definite = 15.93 (13.06-19.41)
*Gram-neg definite = 14.33 (11.60-18.35)
*Gram-pos possible = 20.74 (14.36-25.80)
*contams = 24.48 (21.19-32.27)
*yeast = 32.50 (20.08-44.54)
*uncommon paths = 24.90 (17.67-39.07)
14/ Sub-specialty analysis was also performed based on the patient's treatment team:
Of the 2,121 pts with 1st pos blood cultures:
*21% = Hem/Onc/BMT
*15% = PICU
*10%=GI
*14% = NICU
*9% = CICU
Remainder = hospital medicine service
15 /
*When comparing the TTPs for all treated pathogens among the NICU, PICU and CICU, there wasn't a difference between groups

*Longer median TTPs were observed in the NICU with MSSA, MRSA, and Streptococcus species.
16 / Putting it all together:
1. This study suggests that 36 hours is sufficient for observation of blood cultures in infants and children who are receiving empiric antimicrobial treatment out of concern for bacteremia (87% of BCs positive by 36 hours).
17/

2. This study suggests that early de-escalation is appropriate in a clinically stable patient. This will likely require safety-netting with robust education, strict return precautions, etc.
18/

3. The longest median TTP in this study was for yeast, at 32.50 hours.

4. There was no significant difference in TTP w/ respect to source (CVC vs peripheral draw) or treatment team.

**These findings are consistent with previously published literature
19 / Why is this unique?
Size, pathogen type 🦠, treatment team💊!
To quote from the manuscript:
With this study, we wanted
to address the common statement heard on
#stewardship rounds of “that study was not
done in patients similar to mine.”
20/
If you just want the overarching conclusion of the study, it's this:
"The probability of true bacteremia after 36 hrs is low enough that the # of children needed to be treated beyond that time window to prevent 1 case of
premature termination is likely excessive"
#Stewardship
21/ The impact:
If practice was changed to 36 hours hospital-wide, thousands of days of unnecessary antimicrobial therapy could be avoided, also reducing associated downstream effects of such therapy.
#IDTwitter
22/
This was led by PharmD extraordinaire @ChristineMacBr1 and senior authored by the one and only @HandshakeASP -- both of which run a powerful #stewardship team at @ChildrensColo. Work would not have been possible without Manon Williams, Kelly Pearce and Dustin Lamb as well.
And for those who would like it all wrapped up nice and pretty...

@threadreaderapp unroll

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Andrea Prinzi SM(ASCP), MPH, CPH🧫🔬

Andrea Prinzi SM(ASCP), MPH, CPH🧫🔬 Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @andreaprinzi

3 Sep
1/ Happy Friday!
Today I am celebrating #scicomm! As of this week, I have contributed 21 articles to the @ASMicrobiology Bugs & Drugs blog! Here's a recap of some of these articles for those who love clinical #microbiology
#IDTwitter @ASCLS @CUAnschutz #MedEd @JClinMicro
2/ First, just a quick note on writing for @ASMicrobiology. Volunteering my time to write has been one of the highlights of the last 2 yrs for me! So grateful for the amazing Bugs & Drugs team, especially @JulieMarieWolf @JClinMicro @ScienceInTheDMV who took a chance on me.
3/
YELLOW FEVER AND FRACTIONAL DOSES
#Publichealth piece discussing the yellow fever outbreak of 2015/16 in Africa & highlighting the amazing work of researchers working on fractional #vaccine dosing. It's an amazing story, full of impressive characters.
asm.org/Articles/2021/…
Read 19 tweets
1 Sep
1/ I loved writing this new @ASMicrobiology article. I talked to Dr. Derick Kimathi (@Toinoti, medical researcher in Kenya), about using fractional doses of yellow fever #vaccine. I hope you find this as interesting as I did #IDtwitter #epitwitter
asm.org/Articles/2021/…
2 / This is a follow up article to the one I wrote back in May that briefly detailed the history of #YellowFever in the United States, and how the development of #diagnostics for the disease as well as modern research stemmed from that #history.
asm.org/Articles/2021/…
3/ The #YellowFever #outbreak that started in Angola in 2015 ravaged major cities like Luanda & Kinshasa, and resulted in 11 imported cases in China - a country that harbors the mosquito that spreads the yellow fever virus and has a population immunologically naïve to YF.
Read 8 tweets
7 Apr
1/I want to take some time to share findings from our semi-recent PETACS study. This was a wonderful collaboration between @COpedsID faculty, survey designers, and #microbiologists across the US.
@JClinMicro @ASMicrobiology #ASMClinMicro
jcm.asm.org/content/59/3/e…
2/ First, I want to emphasize that this project highlights many of the reasons I chose to pursue a #PhD in clinical & translational science. As a long-time microbiologist, I can say that the clinical lab doesn't often have a seat at the clinical effectiveness / research table.
3/ This project focuses on the tracheal aspirate culture- a diagnostic process that is greatly limited by contamination with normal respiratory flora, and which lacks consensus or standardization across labs and hospitals. @ASCLS @ASMicrobiology @ASCP_Chicago
Read 26 tweets
30 Mar
1/Dr. Lewis Roberts is giving a really interesting talk at @ACTScience #TS21 that walks us through the art of reviewing and questioning a scientific talk.

We are all pretty familiar with reviewing manuscripts, but I think this is a fresh take!
@EdgeforScholars #phdlife #PhD
2/
This is like a dynamic (real-time) manuscript review. The corollary:
* One key for presenters: strategically repeat yourself
*Tell them what you're going to say (abstract)
*Tell them (introduction, methods, results)
*Tell them what you told them (discussion)
#TS21 @ACTScience
3/
The 40,000 ft view:
*What is the main aim of the study? Should be in the first few minutes of a presentation
*When you are listening, pick out:
-What is the problem they are trying to solve?
-What is the overall hypothesis?
#TS21
Read 7 tweets
30 Mar
1/ Dr. Stephen Ekker (@scekker) is speaking my language in his talk about the importance of #scicomm and how effective @Twitter can be for scientists.
#TS21 @EdgeforScholars @ACTScience
2/ Good science communication IS good science ethics!
Effectively communicating our science literally has life-saving implications, and it is VERY important.
#scicomm #TS21 @ACTScience @EdgeforScholars
#phdlife #PhD @CCTSI
3/ Making your own "Scientist Oath" using social media:
If you were making your own platform, what rules would YOU write?
-Be deliberate in thinking about what you share and how you share it
Read 10 tweets
30 Mar
1/Listening to an amazing plenary talk by @DrCHWilkins on racism, disparities, and the role of race/ethnicity in medicine and research. AMAZING talk!
#TS21 @EdgeforScholars @ACTScience
2/Our focus always seems to be on race alone, and not on other social scenarios. We focus so much on personal choices and access to care-- but we focus less on disparities the way we should (and race as a fully sociopolitical concept).
#TS21 @ACTScience
3/*Racism in medicine is =responsible for minorities having the worst healthcare & outcomes in the US
*Many famous physicians & scientists were involved in creating and perpetuating inferiority stereotypes
*Many continue to conflate race with biology & physiology
#TS21
Read 15 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!

:(